DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
5,580.00
+90.00 (1.64%)
At close: Oct 2, 2025
DongKoo Bio & Pharma Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cash & Equivalents | 5,555 | 25,372 | 15,713 | 12,514 | 19,557 | 4,881 | Upgrade |
Short-Term Investments | 506.9 | 506.9 | 1,941 | 1,351 | 143.14 | 87.57 | Upgrade |
Trading Asset Securities | 10,399 | 10,371 | 5,245 | 21,271 | 12,399 | 24,616 | Upgrade |
Cash & Short-Term Investments | 16,461 | 36,250 | 22,898 | 35,136 | 32,100 | 29,585 | Upgrade |
Cash Growth | -29.94% | 58.31% | -34.83% | 9.46% | 8.50% | 168.63% | Upgrade |
Accounts Receivable | 22,575 | 19,876 | 19,879 | 18,503 | 15,774 | 17,455 | Upgrade |
Other Receivables | 288.22 | 1,352 | 1,570 | 898.47 | 633.49 | 136.73 | Upgrade |
Receivables | 26,034 | 23,953 | 22,449 | 19,402 | 16,408 | 17,592 | Upgrade |
Inventory | 59,547 | 45,962 | 42,606 | 31,428 | 24,964 | 24,971 | Upgrade |
Prepaid Expenses | 476.82 | 324.71 | 216.61 | 225.89 | 229.66 | 200.1 | Upgrade |
Other Current Assets | 1,220 | 751.62 | 195.02 | 1,226 | 131.5 | 4.72 | Upgrade |
Total Current Assets | 103,739 | 107,242 | 88,365 | 87,417 | 73,832 | 72,353 | Upgrade |
Property, Plant & Equipment | 65,528 | 66,222 | 50,483 | 39,681 | 40,051 | 40,377 | Upgrade |
Long-Term Investments | 71,137 | 50,419 | 39,800 | 33,619 | 35,498 | 26,495 | Upgrade |
Other Intangible Assets | 5,473 | 13,172 | 10,903 | 9,010 | 3,048 | 2,081 | Upgrade |
Long-Term Accounts Receivable | - | - | - | - | - | 16.66 | Upgrade |
Long-Term Deferred Tax Assets | 3,797 | 3,162 | 291.5 | 6.95 | - | - | Upgrade |
Other Long-Term Assets | 2,237 | 3,843 | 1,260 | 2,325 | 2,358 | 3,031 | Upgrade |
Total Assets | 259,312 | 244,061 | 191,103 | 172,059 | 154,786 | 144,353 | Upgrade |
Accounts Payable | 14,966 | 15,591 | 11,202 | 14,300 | 11,591 | 9,191 | Upgrade |
Accrued Expenses | 11,156 | 11,337 | 10,274 | 9,637 | 6,496 | 4,683 | Upgrade |
Short-Term Debt | 74,487 | 74,876 | 40,500 | 33,000 | 18,070 | 18,000 | Upgrade |
Current Portion of Long-Term Debt | 1,750 | - | - | - | 5,000 | - | Upgrade |
Current Portion of Leases | 631.52 | 681.03 | 842.63 | 567.83 | 453.23 | 523.99 | Upgrade |
Current Income Taxes Payable | 1,072 | 3,325 | 1,638 | 2,576 | 1,978 | 915.59 | Upgrade |
Other Current Liabilities | 8,102 | 9,441 | 8,863 | 5,963 | 6,434 | 7,194 | Upgrade |
Total Current Liabilities | 112,163 | 115,251 | 73,318 | 66,044 | 50,022 | 40,508 | Upgrade |
Long-Term Debt | 19,122 | 10,467 | 1,447 | - | - | 5,000 | Upgrade |
Long-Term Leases | 434.37 | 616.95 | 1,014 | 754.22 | 770.27 | 219.01 | Upgrade |
Long-Term Deferred Tax Liabilities | 4.1 | 8.89 | 4.5 | 140.93 | 2,315 | 3,034 | Upgrade |
Other Long-Term Liabilities | 15,455 | 12,269 | 4,596 | 3,015 | 1,350 | 939.53 | Upgrade |
Total Liabilities | 147,178 | 138,613 | 80,658 | 69,953 | 54,662 | 49,701 | Upgrade |
Common Stock | 14,232 | 14,232 | 14,232 | 14,232 | 14,232 | 4,802 | Upgrade |
Additional Paid-In Capital | 33,562 | 33,063 | 33,063 | 33,063 | 33,063 | 42,569 | Upgrade |
Retained Earnings | 74,689 | 67,320 | 69,735 | 61,675 | 57,158 | 49,727 | Upgrade |
Treasury Stock | -10,545 | -10,545 | -7,137 | -7,058 | -4,062 | -2,065 | Upgrade |
Comprehensive Income & Other | 142.46 | 1,261 | 507.18 | 193.39 | -266.18 | -380.89 | Upgrade |
Total Common Equity | 112,081 | 105,332 | 110,400 | 102,106 | 100,124 | 94,653 | Upgrade |
Minority Interest | 53.22 | 116.03 | 44.92 | - | - | - | Upgrade |
Shareholders' Equity | 112,134 | 105,448 | 110,445 | 102,106 | 100,124 | 94,653 | Upgrade |
Total Liabilities & Equity | 259,312 | 244,061 | 191,103 | 172,059 | 154,786 | 144,353 | Upgrade |
Total Debt | 96,425 | 86,641 | 43,804 | 34,322 | 24,294 | 23,743 | Upgrade |
Net Cash (Debt) | -79,964 | -50,391 | -20,906 | 813.88 | 7,806 | 5,842 | Upgrade |
Net Cash Growth | - | - | - | -89.57% | 33.61% | - | Upgrade |
Net Cash Per Share | -2912.53 | -1845.19 | -756.89 | 29.32 | 276.23 | 206.49 | Upgrade |
Filing Date Shares Outstanding | 27.04 | 27.04 | 27.61 | 27.62 | 28.04 | 28.29 | Upgrade |
Total Common Shares Outstanding | 27.04 | 27.04 | 27.61 | 27.62 | 28.04 | 28.29 | Upgrade |
Working Capital | -8,424 | -8,009 | 15,046 | 21,374 | 23,811 | 31,844 | Upgrade |
Book Value Per Share | 4144.68 | 3895.10 | 3998.84 | 3696.33 | 3570.78 | 3345.63 | Upgrade |
Tangible Book Value | 106,608 | 92,160 | 99,497 | 93,096 | 97,076 | 92,572 | Upgrade |
Tangible Book Value Per Share | 3942.28 | 3408.02 | 3603.92 | 3370.16 | 3462.08 | 3272.08 | Upgrade |
Land | 13,262 | 13,262 | 10,849 | 10,849 | 10,584 | 10,584 | Upgrade |
Buildings | 27,913 | 39,356 | 29,667 | 27,353 | 26,899 | 26,120 | Upgrade |
Machinery | 11,195 | 30,310 | 19,768 | 17,741 | 17,813 | 16,838 | Upgrade |
Construction In Progress | 8,237 | 7,823 | 10,694 | 1,451 | 887.9 | 844.54 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.